LIVZON Financial Statements From 2010 to 2024
| LP6 Stock | EUR 3.40 0.18 5.59% |
Check LIVZON PHARMAC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LIVZON PHARMAC's main balance sheet or income statement drivers, such as , as well as many indicators such as . LIVZON financial statements analysis is a perfect complement when working with LIVZON PHARMAC Valuation or Volatility modules.
LIVZON |
LIVZON PHARMAC GRP Company Return On Asset Analysis
LIVZON PHARMAC's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current LIVZON PHARMAC Return On Asset | 0.0514 |
Most of LIVZON PHARMAC's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LIVZON PHARMAC GRP is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, LIVZON PHARMAC GRP has a Return On Asset of 0.0514. This is 100.59% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers-Specialty & Generic industry. The return on asset for all Germany stocks is 136.71% lower than that of the firm.
LIVZON PHARMAC GRP Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining LIVZON PHARMAC's current stock value. Our valuation model uses many indicators to compare LIVZON PHARMAC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LIVZON PHARMAC competition to find correlations between indicators driving LIVZON PHARMAC's intrinsic value. More Info.LIVZON PHARMAC GRP is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.39 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for LIVZON PHARMAC GRP is roughly 2.59 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LIVZON PHARMAC's earnings, one of the primary drivers of an investment's value.About LIVZON PHARMAC Financial Statements
LIVZON PHARMAC stakeholders use historical fundamental indicators, such as LIVZON PHARMAC's revenue or net income, to determine how well the company is positioned to perform in the future. Although LIVZON PHARMAC investors may analyze each financial statement separately, they are all interrelated. For example, changes in LIVZON PHARMAC's assets and liabilities are reflected in the revenues and expenses on LIVZON PHARMAC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in LIVZON PHARMAC GRP. Please read more on our technical analysis and fundamental analysis pages.
Livzon Pharmaceutical Group Inc. engages in the research, development, production, and distribution of pharmaceutical products in the Peoples Republic of China. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, China. Livzon Pharmaceutical operates under Drug Manufacturers - Specialty Generic classification in Germany and traded on Frankfurt Stock Exchange. It employs 6963 people.
Currently Active Assets on Macroaxis
Other Information on Investing in LIVZON Stock
LIVZON PHARMAC financial ratios help investors to determine whether LIVZON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LIVZON with respect to the benefits of owning LIVZON PHARMAC security.